Understanding Differences in Sex-Based Outcomes with Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
- PMID: 38809374
- DOI: 10.1007/s40265-024-02041-4
Understanding Differences in Sex-Based Outcomes with Dual Antiplatelet Therapy After Percutaneous Coronary Intervention
Comment on
-
Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis.Drugs. 2024 Jun;84(6):685-701. doi: 10.1007/s40265-024-02034-3. Epub 2024 May 29. Drugs. 2024. PMID: 38809372
Similar articles
-
Comparison of 1-month vs. 12-month dual antiplatelet therapy after implantation of drug-eluting stents in patients with acute coronary syndrome: the ULTIMATE-DAPT trial.Eur Heart J Acute Cardiovasc Care. 2024 May 7;13(4):368-369. doi: 10.1093/ehjacc/zuae048. Eur Heart J Acute Cardiovasc Care. 2024. PMID: 38598480 Clinical Trial. No abstract available.
-
Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.Circulation. 2020 Jul 21;142(3):306-308. doi: 10.1161/CIRCULATIONAHA.120.047729. Epub 2020 Jul 20. Circulation. 2020. PMID: 32687440 Free PMC article. No abstract available.
-
Determinants and Clinical Outcomes of Extended Dual Antiplatelet Therapy over 3 Years after Drug-Eluting Stent Implantation: A Retrospective Analysis.Yonsei Med J. 2020 Jul;61(7):597-605. doi: 10.3349/ymj.2020.61.7.597. Yonsei Med J. 2020. PMID: 32608203 Free PMC article.
-
Optimizing Dual Antiplatelet Therapy in the Perioperative Period for Spine Surgery After Recent Percutaneous Coronary Intervention: A Comprehensive Review, Synthesis, and Catalyst for Protocol Formulation.World Neurosurg. 2024 May;185:267-278. doi: 10.1016/j.wneu.2024.03.005. Epub 2024 Mar 7. World Neurosurg. 2024. PMID: 38460814 Review.
-
Meta-analysis of Dual Antiplatelet Therapy Versus Monotherapy With P2Y12 Inhibitors in Patients After Percutaneous Coronary Intervention.Am J Cardiol. 2020 Jul 15;127:25-29. doi: 10.1016/j.amjcard.2020.04.027. Epub 2020 Apr 22. Am J Cardiol. 2020. PMID: 32389351 Review.
References
-
- Byrne RA, Rossello X, Coughlan JJ, et al. 2023 ESC guidelines for the management of acute coronary syndrome. Eur Heart J. 2023;44:3270–826. - DOI
-
- Agbaedeng TA, Noubiap JJ, Roberts KA, et al. Sex-based outcomes of dual-antiplatelet therapy after percutaneous coronary intervention: a pairwise and network meta-analysis. Drugs. https://doi.org/10.1007/s40265-024-02034-3 (in press)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical